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ScienceDirectMicrobes colonising the infant intestine, especially bacteria, are
considered important for metabolic and immunological
programming in early life, potentially affecting the susceptibility
of the host to disease. We combined published data to provide
a global view of microbiota development in early life. The results
support the concept that the microbiota develops with age in
an orchestrated manner, showing common patterns across
populations. Furthermore, infants are colonised at birth by
specific, selected maternal faecal bacteria and likely their
bacteriophages. Therefore, infants are adapted to receiving
specific bacterial signals, partly derived from the maternal
microbiota, at successive immunological time windows during
early development. Birth by caesarean section compromises
the initial vertical transmission of microbes whereas antibiotic
use shifts the microbiota away from the normal developmental
pattern. These disruptions alter the microbial signals that the
host receives, potentially affecting child development.
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Introduction
Infants are colonised by microbes at birth, and over the first
years of life the microbes form stable communities, termed
microbiota, on all body surfaces. The microbiota consists of
bacteria, archaea, viruses and fungi, different species living
in different parts of the body depending on the ecological
requirements of the microbial species. The bacterial com-
ponent of the microbiota has been extensively investigated,
while considerably less is currently known on the other
microbes colonising infants. The intestine is the largest
body surface with a very high density of microbes, mainlyCurrent Opinion in Microbiology 2018, 44:70–78 anaerobic bacteria. The microbes in the gut are in constant
contact and interaction with host cells [1]. The reciprocal
interaction of bacteria and immune cells plays an important
role during the time when the immune system is develop-
ing: signals from the gut microbiota are thought to be
important for proper immune maturation and the develop-
ment of tolerance towards benign microbes [1]. Further-
more, the gut microbiota has strong effects on host energy
metabolism, especially in early life [2,3,4,5], via degra-
dation of non-digestible food components [2,3], produc-
tion of short-chain fatty acids that the host cells use as an
energy source [4], metabolism of hormone-like bile acids
[6], production of inflammatory and anti-inflammatory sig-
nals to the host [1], and by influencing hormone levels [7],
gene expression in the liver [8], and overall energy use and
storage in adipose and muscle tissue [9]. Thus, the micro-
biota is considered important for metabolic and immuno-
logical programming in early life, potentially affecting both
current growth [2,3,5], and the long-term susceptibility
of the host to diet-induced metabolic disease [10].
Materials and methods
Several dozens of recent studies have addressed the
development of infant bacterial microbiota since birth
(Supplementary Table 1). In order to effectively summa-
rise the existing data, we collected data on the average
relative abundance of the five most abundant bacterial
classes from the early life microbiota studies (N = 34)
where this information was available and accessible. In
most studies it was possible to obtain the data separately
for the different birth modes and antibiotic-treated and
non-treated groups, but data from formula-fed and
breastfed infants were usually not presented separately.
When possible, we collected information on the propor-
tion of breastfed (exclusively or partially) infants in the
cohort. Information on the proportion of breastfed infants
was available for 30 of the 34 studies.
Significance of associations between the relative abundance
of selected bacterial taxa and age, proportion breastfed, birth
mode, antibiotic use, and location were assessed using linear
regression or analysis of variance models, weighted by the
cohort size. The associations with age, breastfeeding and
location were tested among the vaginally born, non-antibi-
otic-treated cohorts (termed ‘normal’ cohorts).
Temporal development of the gut microbiota
Already during birth, infants are exposed to a large
diversity of maternal and environmental microbes, some
of which find a suitable habitat on the infant body.www.sciencedirect.com
Early life colonization of the human gut: microbes matter everywhere Korpela and de Vos 71Immediately after birth, the bacterial communities that
the infant has been exposed to, such as maternal vaginal
or skin bacteria, can be detected on the infant [11].
However, these communities do not colonise the infant
as such [12]: only the microbes that are adapted to the
conditions present in the different body sites of the infant
can survive: the environment thus selects which microbes
colonise which body surface.
After the initial colonisation, considerable temporal fluctu-
ation of the gut microbiota composition takes place during
the first years of life. In spite of different sample processing
procedures, phylogenetic approaches, and geographic loca-
tion of the cohorts, it is of interest to note that a common
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www.sciencedirect.com are combined (Figure 1). Typically during the first days of
life, aerobic and facultative bacteria, such as streptococci
and enterobacteria dominate the infant gut community
(Figure 1a, b). It is assumed that the gut environment
becomes increasingly anoxic with age, although actual
luminal oxygen levels have not been determined in infants
[13]. Presumably the reduction in oxygen levels enables
anaerobic bacteria to grow, as bifidobacteria commonly
become the most abundant member during the first weeks
of life (Figure 1c). In some infants, Bacteroides spp. form a
large fraction of the microbiota from early on (Figure 1d),
while in others, these remain a minority and Bifidobacterium
spp. dominate. Unlike the other taxa, Bacteroides spp. do not
appear to follow an age-associated developmental pattern,
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72 MicrobiotaBacteroides spp. are adapted to the milk-based diet of
infants, being able to utilise human milk oligosaccharides
(HMOs) as well as similar structures in the host-produced
mucus. The dominance of HMO-utilizing bacteria prevails
normally as long as the infant is breastfed [14]. Once breast
milk is no longer available and the infant’s diet consists of
solid foods, which provide a very different type of fermen-
tation substrates to the bacteria, a major change occurs in
the infant gut. The abundance of bifidobacteria decreases
as they are replaced by clostridia, a diverse group of mainly
anaerobic bacteria specialised in plant polysaccharide deg-
radation (Figure 1e). As recently shown [14], weaning is an
important milestone in the infant gut microbiota develop-
ment,marking the transition from infant-typemicrobiota to
child-type microbiota and initiating the long maturation
process towards adult-like microbiota.
Indeed, part of the observed temporal development
appears to be explained by changes in diet, as the propor-
tion of breastfed infants in the cohort, even when adjusting
for age, was significantly associated with the abundance of
Bacilli ( p = 0.036), bifidobacteria ( p = 0.027), and clostridia
( p < 0.0001) (see unadjusted trends in Supplementary
Figure 1). However, age remained a significant variable
in a multiple regression model adjusting for the proportion
of breastfed infants in the cohort (Bacilli, p = 0.0086; Pro-
teobacteria, p < 0.0001; bifidobacteria, p = 0.0008; clos-
tridia, p = 0.0084), indicating that maturation as such plays
a role independent of diet.
These patterns appear fairly universal in the modern world,
being observed in children from all continents, which
suggests that the timing of the microbiota succession
may be biologically determined, although undoubtedly
affected by local culture, for example via feeding practices.
Thus, infants are likely adapted to receiving specific bac-
terial signals at certain immunological time windows during
early development. We tested for geographical differences
in microbiota composition after adjusting for age (Figure 2).
The most apparent geographical difference in microbiota
development is the lack of clear bifidobacterium domi-
nance in the American cohorts (Figure 1c, Figure 2c);
instead, American children appear to have a relatively high
abundance of Bacteroides spp. (Figure 1d, Figure 2d) and
enterobacteria (Figure 1b, Figure 2b) during the time
window (1–6 months) when bifidobacteria dominate in
other continents. Conversely, African, Asian and Central
European cohorts have high abundances of bifidobacteria
(Figure 1c), and low abundances of clostridia (Figure 1e)
during the first year, implying that theirmicrobiota follows a
relatively slow maturation pattern. The geographical dif-
ferences are even more pronounced when adjusting for the
proportion of breastfed infants in the cohort, but due to
missing breastfeeding data for several cohorts (see Supple-
mentary Table 1), we chose to present the more robust age-
adjusted data. The association between the proportion
breastfed and the microbiota in the different geographicalCurrent Opinion in Microbiology 2018, 44:70–78 locations is shown in Supplementary Figure 1. Overall, the
lowest breastfeedingproportionsamongthe<12 monthold
cohorts were in the Southern (median 63%), Central
(median 70%) and Northern European cohorts (median
76%), while the other cohorts had mostly 100% breastfeed-
ing rates. This suggests that at least not all of the observed
differences are driven by local breastfeeding practices.
However, we found an indication that technical bias may
explain some of the differences. Two Finnish cohorts
[15,16] showed a resemblance to the American cohorts
in terms of low Bifidobacterium and high Bacteroides abun-
dance. These two cohorts were analysed in the US, which is
suggestive that some of the observed differences may be
technical, rather than biological, as has been suggested
previously [17], but this needs further investigation.
While the bacterial microbiota is relatively well defined in
infants across geographic settings, the intestinal virome
and virus-bacterium interactions in infants are just start-
ing to be elucidated. Bacteriophages, especially, are
increasingly being recognized as modulators of the intes-
tinal microbiota in health and disease [18]. A longitudinal
study of 4 twin pairs in a developed country setting
showed that neonates harbour a high diversity of bacter-
iophages, most likely acquired at birth, while eukaryotic
RNA and DNA viruses were mostly acquired postnatally
[19]. The diversity of bacteriophages decreased over the
first two years of life as Microviridae became dominant
[19]. Whether these patterns are general and what drives
these changes in gut virome is currently unclear, but
recent data from two developing countries support the
delayed appearance of eukaryotic viruses [20].
While fungi and other micro-eukarya are found in the
human intestinal tract, their diversity is usually low and
only few dozen species have been described [21,22].
Limited information exist on the early gut mycobiota
but a recent study with close to 300 mothers and their
offspring showed fungi to be detectable as early as a few
days after birth and reported a strong correlation between
the detection of fecal fungal DNA in mothers and their
infants, suggestive of vertical transmission [23]. Similarly,
archaea were detected on a low level in infants from the
very first time points after birth and were more abundant
and prevalent than the fungi. The majority were metha-
nogens, which were more abundant in vaginally born than
in C-section delivered infants [24]. These studies indi-
cate the need to complement studies on bacterial com-
munity development with those addressing viral, archaeal
and microeukaryotic dynamics.
How long the development continues and when the
child microbiota becomes mature, is currently not
known. Some longitudinal studies have shown the devel-
opment to proceed beyond 5 years [25] and the age at
which the microbiota becomes fully mature is yet to be
identified.www.sciencedirect.com
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Geographical differences in microbiota composition. Age-adjusted relative abundance, obtained from the model presented in Figure 1, was used
to test for geographical differences in an analysis of variance model, weighted by the size of the cohort. Tukey HDS test was used to assess the
significance of the pairwise differences. The samples marked with black were omitted from the test. Data collected from available literature
[3,14,20,29,32,34,36,38–60].Where do the microbes come from?
It has long been assumed that infants are colonised by
maternal microbes during birth from the birth canal, and
by microbes present in breast milk. However, it is impor-
tant to note that the ecological conditions in maternal
vagina and breast are different from those in the infant
gut. Even if the same classes of bacteria are observed in
different body sites, the species and strains are likely
highly adapted to the specific body site and thus may be
unable to successfully transfer from one environment to
another. A recent study matched bifidobacterial strains in
the infant to those in maternal breast milk [26], suggest-
ing that such vertical transmission may occur. This is yet
to be verified in large cohorts and likely applies only to
specific taxa. Furthermore, it has been suggested that the
origin of breast milk bacteria is in fact the maternal gut,
allowing gut bacteria to be transmitted via breast milk
[27]. On the contrary, it was recently shown that thewww.sciencedirect.com bacterial taxa present in infant faecal samples are rarely
seen in maternal vaginal samples [12]. The authors
concluded that vaginal bacteria are not transmitted to
the infant. The only adult body site that consistently
contains all the taxa commonly observed in the infant gut
is, not surprisingly, the gut itself. Several studies have
observed the same species or strains present in faecal
samples of infants and their mothers, implying maternal
transmission of faecal bacteria [14,28,29]. It is thus
highly likely that the maternal gut is the main source
of microbes colonising the infant gut.
Establishing a microbial transmission event requires
stringent scientific methods [30]. Many microbial species
and strains are prevalent in the population, and observing
the same species, OTU, or strain in two individuals is not
sufficient evidence of transmission. Deep metagenomic
sequencing coupled with single nucleotide variant (SNV)Current Opinion in Microbiology 2018, 44:70–78
74 Microbiotaanalysis allows sufficiently high genomic resolution to
identify truly rare strains that are very unlikely to be
derived from the environment [28,29,31]. Further-
more, it is possible to follow the strains of all abundant
species simultaneously, extending the analysis from
selected species to large communities of microbes.
Using this approach, various groups, including ours, have
recently verified that maternal faecal bacteria are transmit-
ted to the infant gut and that they colonise persistently
[28,29,31]. However, our data show that not all mater-
nal gut inhabitants are transmitted: only specific maternal
taxa, notably bifidobacteria and bacteroides, colonise the
infant permanently and in a rather dominant way [31].
Although clostridia are the most abundant group of bacteria
in the maternal gut, these were not found to colonise the
infant, at least not in detectable abundance [31]. Inter-
estingly, in a recent study, bacteriophages of bifodobac-
teria, termed bifidophages, were followed in infants and
found to be transmitted vertically, like their bacterial hosts
[26]. This result and the discovery of a diverse bacterio-
phage community in neonates [19] suggest that bacterio-
phages may be transmitted vertically at birth, while this
may not apply to eukaryotic viruses [19,32].
The differences in colonisation ability between bacterial
taxa are likely attributable to the early life milk-based
diet, including the human milk oligosaccharides, which
determines which bacteria are able to grow in the infant
gut. According to our recent results, most of the clostridia
that colonise children are not of maternal origin [31];
where they come from is currently not known. In some
cases the origin may be the father or siblings [31], but
their role has not been fully addressed. It is tempting to
speculate that while bifidobacteria and bacteroides
appear to be directly vertically transmitted at birth, clos-
tridia, which commonly form spores and thus survive
periods outside of their habitat, would rely mainly on
non-direct transmission between hosts, being transmitted
via the environment. This hypothesis has received sup-
port from the finding that many strict anaerobes of the
class Clostridia survive extended exposure to air and
ethanol due to spore formation, while Bacteroides and
Bifidobacterium spp. do not [33]. Furthermore, we have
found that clostridial strains are less stable within indi-
viduals than strains of bifidobacteria and bacteroides
[31], again suggesting that their life history strategy
may be profoundly different.
Impact of disturbances
The most common disturbances to infant colonisation are
perinatal antibiotics and caesarean delivery, which often
co-occur. Several studies have shown clear and long-term
differences in the microbiota composition between vagi-
nally born and caesarean born infants, usually increased
abundance of bacilli (Figure 3a) and enterobacteria
(Figure 3b), reduced abundance of bifidobacteriaCurrent Opinion in Microbiology 2018, 44:70–78 (Figure 3c), and especially a clear and long-term lack
of Bacteroides in the caesarean-born infants (Figure 3e).
Generally, the major differences seem to disappear by the
age of 12 months (Figure 3), but even transient differ-
ences in the pattern of microbiota succession may have
long-term effects on the immunological and metabolic
development of the host [1,34].
In a recent study it was suggested that body site rather
than delivery mode affected the infant microbiota [32].
However, careful re-analysis of these data indicates that
the birth mode effect on the gut microbiota is strong even
after 6 weeks, confirming the general trend (see Supple-
mentary Table 1 and [31]).
As the two taxa that are normally transmitted at birth from
the mother, bifidobacteria and bacteroides, are often
reduced in caesarean born infants, it can be expected
that caesarean birth interferes with vertical transmission
of the gut microbiota. This is exactly what we discovered
in a recent metagenomic study [31]. Infants born by
caesarean section showed a complete lack of maternal
strains during the first weeks of life. Over several months,
they did acquire maternal strains, but there is reason to
believe that this late postnatal colonisation may distort
the timing of the microbial successional phases. It is not
yet known how important the identity of the strains is and
whether replacing the missing maternal strains by e.g.
probiotic bifidobacteria is sufficient to completely nor-
malise the caesarean-born infant microbiota and conse-
quently infant development. The lack of vertical trans-
mission in caesarean-born infants supports the hypothesis
that microbial colonisation normally begins at birth, not in
utero. However, the perinatal use of antibiotics should be
addressed as to eliminate this potentially confounding
factor. Although bacteria are observed in meconium sam-
ples, there is currently no evidence in human to support in
utero colonisation, as concluded in a recent review [35].
Another very common disturbance to infant microbiota is
antibiotic use (Figure 3). Antibiotics given in early life
usually deplete especially the bifidobacterial community
(Figure 3c), increasing the abundance of clostridia
(Figure 3d). This means that infants that are given anti-
biotics during the time when bifidobacteria normally
dominate, will be shifted away from the normal develop-
mental pattern. While the microbiota does recover within
6–12 months, depending on the antibiotic used [36], the
recovery will occur after the time window for bifidobac-
terial dominance has passed. Disruption of the normal
microbiota succession may influence infant development
[5,34]. Indeed early life antibiotic use has been associ-
ated with increased risk of overweight [37], countering
the protective effects of breastfeeding that are likely
mediated by the microbiota [37]. In a recent study,
we found an increased level of antibiotic resistance genes
as a function of the number of antibiotic courses given to awww.sciencedirect.com
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Comparison of the microbiota development in the caesarean born and in the antibiotic-treated children to the normal development. Data collected
from available literature [3,14,20,29,32,34,36,38–60]. The p-values in the top left corner refer to the significance of the difference before or at
age 3 months, and the p-values in the top right corner after age 3 months. The p-values were obtained linear regression models adjusting for age.child [36], indicating that the observed associations may
be causal. A causal relation is further supported by studies
in mice that upon repeated treatment with antibiotics,
developed obesity and other metabolic defects [10].
Conclusion
The intimate interactions between host development and
intestinal microbiota have been documented, but only
now insight is emerging on how finely tuned the coloni-
sation process is and what impact the disturbances in early
life may have on later life health. Our analysis of global
data has revealed common patterns in the way the child
microbiota is disrupted by caesarean birth and antibiotic
use. Since these large-scale disturbances affect a signifi-
cant proportion of the human population, targeted treat-
ment approaches are needed. Knowledge on the devel-
opment of infant microbiota provides opportunities to
normalize the impact of disturbances. Development of
specific probiotic (live bacteria), prebiotic (oligosacchar-
ides, fibres) and postbiotic (products of bacterial metabo-
lism such as short-chain fatty acids and secondary bile
acids) products, aimed to support a natural microbiota at
different ages and targeting specific defects will be an
important next step to take the microbiome field from
description to treatment.www.sciencedirect.com Conflict of interest statement
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crosstalk between bile acids and microbiota and its impact on
host metabolism. Cell Metabol 2016, 24:41-50.
7. Clarke G, Stilling RM, Kennedy PJ, Stanton C, Cryan JF, Dinan TG:
Minireview: Gut microbiota: the neglected endocrine organ.
Mol Endocrinol 2014, 28:1221-1238.
8. Caesar R, Nygren H, Oresic M, Backhed F: Interaction between
dietary lipids and gut microbiota regulates hepatic cholesterol
metabolism. J Lipid Res 2016, 57:474-481.
9. Rosenbaum M, Knight R, Leibel RL: The gut microbiota in human
energy homeostasis and obesity. Trends Endocrinol Metabol
2015, 26:493-501.
10. Cox LM, Yamanishi S, Sohn J, Alekseyenko AV, Leung JM, Cho I,
Kim SG, Li H, Gao Z, Mahana D: Altering the intestinal
microbiota during a critical developmental window has lasting
metabolic consequences. Cell 2014, 158:705-721.
11. Dominguez-Bello MG, Costello EK, Contreras M, Magris M,
Hidalgo G, Fierer N, Knight R: Delivery mode shapes the
acquisition and structure of the initial microbiota across




Sakwinska O, Foata F, Berger B, Brüssow H, Combremont S,
Mercenier A, Dogra S, Soh S, Yen J, Heong G: Does the maternal
vaginal microbiota play a role in seeding the microbiota of
neonatal gut and nose? Benef Microbes 2017, 8:763-778.
Analysing the microbiota composition in infant faecal and nose swab
samples and maternal vaginal, skin, and rectal samples, the authors
conclude that there is limited vertical transmission from the maternal to
the infant body sites. Faecal samples of the mother are, however, not
analysed.
13. Albenberg L, Esipova TV, Judge CP, Bittinger K, Chen J,
Laughlin A, Grunberg S, Baldassano RN, Lewis JD, Li H, Thom SR,
Bushman FD, Vinogradov SA, Wu GD: Correlation between
intraluminal oxygen gradient and radial partitioning of
intestinal microbiota in humans and mice. Gastroenterology
2014, 147:1055-1063 e8.
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